149 related articles for article (PubMed ID: 38002934)
21. [Hereditary kidney cancers: The pathologist's view in 2020].
Verkarre V; Morini A; Denize T; Ferlicot S; Richard S
Ann Pathol; 2020 Apr; 40(2):148-167. PubMed ID: 32197858
[TBL] [Abstract][Full Text] [Related]
22. Detection of Pathogenic Germline Variants Among Patients With Advanced Colorectal Cancer Undergoing Tumor Genomic Profiling for Precision Medicine.
You YN; Borras E; Chang K; Price BA; Mork M; Chang GJ; Rodriguez-Bigas MA; Bednarski BK; Meric-Bernstam F; Vilar E
Dis Colon Rectum; 2019 Apr; 62(4):429-437. PubMed ID: 30730459
[TBL] [Abstract][Full Text] [Related]
23. Association of Pathogenic Variants in Hereditary Cancer Genes With Multiple Diseases.
Zeng C; Bastarache LA; Tao R; Venner E; Hebbring S; Andujar JD; Bland ST; Crosslin DR; Pratap S; Cooley A; Pacheco JA; Christensen KD; Perez E; Zawatsky CLB; Witkowski L; Zouk H; Weng C; Leppig KA; Sleiman PMA; Hakonarson H; Williams MS; Luo Y; Jarvik GP; Green RC; Chung WK; Gharavi AG; Lennon NJ; Rehm HL; Gibbs RA; Peterson JF; Roden DM; Wiesner GL; Denny JC
JAMA Oncol; 2022 Jun; 8(6):835-844. PubMed ID: 35446370
[TBL] [Abstract][Full Text] [Related]
24. Male breast cancer in a multi-gene panel testing cohort: insights and unexpected results.
Pritzlaff M; Summerour P; McFarland R; Li S; Reineke P; Dolinsky JS; Goldgar DE; Shimelis H; Couch FJ; Chao EC; LaDuca H
Breast Cancer Res Treat; 2017 Feb; 161(3):575-586. PubMed ID: 28008555
[TBL] [Abstract][Full Text] [Related]
25. Germline whole genome sequencing in adults with multiple primary tumors.
Wang Y; Ding Q; Prokopec S; Farncombe KM; Bruce J; Casalino S; McCuaig J; Szybowska M; van Engelen K; Lerner-Ellis J; Pugh TJ; Kim RH
Fam Cancer; 2023 Oct; 22(4):513-520. PubMed ID: 37481477
[TBL] [Abstract][Full Text] [Related]
26. Detection of germline variants in Brazilian breast cancer patients using multigene panel testing.
Guindalini RSC; Viana DV; Kitajima JPFW; Rocha VM; López RVM; Zheng Y; Freitas É; Monteiro FPM; Valim A; Schlesinger D; Kok F; Olopade OI; Folgueira MAAK
Sci Rep; 2022 Mar; 12(1):4190. PubMed ID: 35264596
[TBL] [Abstract][Full Text] [Related]
27. Exploring the hereditary background of renal cancer in Denmark.
Christensen MB; Wadt K; Jensen UB; Lautrup CK; Bojesen A; Krogh LN; Overeem Hansen TV; Gerdes AM
PLoS One; 2019; 14(4):e0215725. PubMed ID: 31034483
[TBL] [Abstract][Full Text] [Related]
28. Statewide Retrospective Review of Familial Pancreatic Cancer in Delaware, and Frequency of Genetic Mutations in Pancreatic Cancer Kindreds.
Catts ZA; Baig MK; Milewski B; Keywan C; Guarino M; Petrelli N
Ann Surg Oncol; 2016 May; 23(5):1729-35. PubMed ID: 26727920
[TBL] [Abstract][Full Text] [Related]
29. Gene Panel Testing in Hereditary Breast Cancer.
Rostami P; Zendehdel K; Shirkoohi R; Ebrahimi E; Ataei M; Imanian H; Najmabadi H; Akbari MR; Sanati MH
Arch Iran Med; 2020 Mar; 23(3):155-162. PubMed ID: 32126783
[TBL] [Abstract][Full Text] [Related]
30. Germline variants in cancer genes in high-risk non-BRCA patients from Puerto Rico.
Dutil J; Teer JK; Golubeva V; Yoder S; Tong WL; Arroyo N; Karam R; Echenique M; Matta JL; Monteiro AN
Sci Rep; 2019 Nov; 9(1):17769. PubMed ID: 31780696
[TBL] [Abstract][Full Text] [Related]
31. Diagnostic yield and clinical relevance of expanded genetic testing for cancer patients.
Ceyhan-Birsoy O; Jayakumaran G; Kemel Y; Misyura M; Aypar U; Jairam S; Yang C; Li Y; Mehta N; Maio A; Arnold A; Salo-Mullen E; Sheehan M; Syed A; Walsh M; Carlo M; Robson M; Offit K; Ladanyi M; Reis-Filho JS; Stadler ZK; Zhang L; Latham A; Zehir A; Mandelker D
Genome Med; 2022 Aug; 14(1):92. PubMed ID: 35971132
[TBL] [Abstract][Full Text] [Related]
32. Moderate penetrance genes complicate genetic testing for breast cancer diagnosis: ATM, CHEK2, BARD1 and RAD51D.
Graffeo R; Rana HQ; Conforti F; Bonanni B; Cardoso MJ; Paluch-Shimon S; Pagani O; Goldhirsch A; Partridge AH; Lambertini M; Garber JE
Breast; 2022 Oct; 65():32-40. PubMed ID: 35772246
[TBL] [Abstract][Full Text] [Related]
33. Evaluation of a Four-Gene Panel for Hereditary Cancer Risk Assessment.
Secondino A; Starnone F; Veneruso I; Di Tella MA; Conato S; De Angelis C; De Placido S; D'Argenio V
Genes (Basel); 2022 Apr; 13(4):. PubMed ID: 35456488
[No Abstract] [Full Text] [Related]
34. Identification of a Variety of Mutations in Cancer Predisposition Genes in Patients With Suspected Lynch Syndrome.
Yurgelun MB; Allen B; Kaldate RR; Bowles KR; Judkins T; Kaushik P; Roa BB; Wenstrup RJ; Hartman AR; Syngal S
Gastroenterology; 2015 Sep; 149(3):604-13.e20. PubMed ID: 25980754
[TBL] [Abstract][Full Text] [Related]
35. Whole Exome Sequencing Identifies Candidate Genes Associated with Hereditary Predisposition to Uveal Melanoma.
Abdel-Rahman MH; Sample KM; Pilarski R; Walsh T; Grosel T; Kinnamon D; Boru G; Massengill JB; Schoenfield L; Kelly B; Gordon D; Johansson P; DeBenedictis MJ; Singh A; Casadei S; Davidorf FH; White P; Stacey AW; Scarth J; Fewings E; Tischkowitz M; King MC; Hayward NK; Cebulla CM
Ophthalmology; 2020 May; 127(5):668-678. PubMed ID: 32081490
[TBL] [Abstract][Full Text] [Related]
36. Frequency of pathogenic germline mutation in CHEK2, PALB2, MRE11, and RAD50 in patients at high risk for hereditary breast cancer.
Kim H; Cho DY; Choi DH; Oh M; Shin I; Park W; Huh SJ; Nam SJ; Lee JE; Kim SW
Breast Cancer Res Treat; 2017 Jan; 161(1):95-102. PubMed ID: 27783279
[TBL] [Abstract][Full Text] [Related]
37. Population-based Screening for Hereditary Colorectal Cancer Variants in Japan.
Fujita M; Liu X; Iwasaki Y; Terao C; Mizukami K; Kawakami E; Takata S; Inai C; Aoi T; Mizukoshi M; Maejima K; Hirata M; Murakami Y; Kamatani Y; Kubo M; Akagi K; Matsuda K; Nakagawa H; Momozawa Y
Clin Gastroenterol Hepatol; 2022 Sep; 20(9):2132-2141.e9. PubMed ID: 33309985
[TBL] [Abstract][Full Text] [Related]
38. Defining early-onset kidney cancer: implications for germline and somatic mutation testing and clinical management.
Shuch B; Vourganti S; Ricketts CJ; Middleton L; Peterson J; Merino MJ; Metwalli AR; Srinivasan R; Linehan WM
J Clin Oncol; 2014 Feb; 32(5):431-7. PubMed ID: 24378414
[TBL] [Abstract][Full Text] [Related]
39. Screening for BRCA1, BRCA2, CHEK2, PALB2, BRIP1, RAD50, and CDH1 mutations in high-risk Finnish BRCA1/2-founder mutation-negative breast and/or ovarian cancer individuals.
Kuusisto KM; Bebel A; Vihinen M; Schleutker J; Sallinen SL
Breast Cancer Res; 2011 Feb; 13(1):R20. PubMed ID: 21356067
[TBL] [Abstract][Full Text] [Related]
40. Novel Germline Mutations in a Cohort of Men with Familial Prostate Cancer.
Mondschein R; Bolton D; Clouston D; Dowty J; Kavanagh L; Murphy D; Scott P; Taylor RA; Thorne H
Cancers (Basel); 2022 Jul; 14(15):. PubMed ID: 35892882
[No Abstract] [Full Text] [Related]
[Previous] [Next] [New Search]
